As of 2024, companies have paid millions to settle transvaginal mesh lawsuits in 48 states, and they’ve paid out an estimated $8 billion in transvaginal mesh verdicts and settlements to individuals. While 95% of transvaginal mesh lawsuits have been settled, lawyers continue to take cases.
This is an active lawsuitIf you suffered serious complications from your transvaginal mesh, you may be entitled to compensation. Get a free case review today.
Editors carefully fact-check all Drugwatch.com content for accuracy and quality.
Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.
We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
As of September 2024 , about 95% of transvaginal mesh lawsuits have been resolved through settlements or jury verdicts, but lawyers are still accepting cases for potential settlement or trial.
It’s estimated that manufacturers have paid more than $8 billion in settlements and verdicts to resolve these cases, and the litigation continues. In February 2023, Ethicon paid a $9.9 million settlement to the state of Kentucky to resolve claims that the company failed to disclose the risks of its transvaginal mesh devices.
“Since we have no exact numbers on how many patients received these products, I expect [adverse event reports for transvaginal mesh] to increase as the public becomes more aware of the FDA’s regulatory updates regarding mesh that was used for pelvic organ prolapse (POP) repairs.”
Tess Schulman, Ph.D. CERTIFIED PARALEGALMost of Ethicon’s transvaginal mesh settlements for individual plaintiffs have been for undisclosed amounts. It quietly settled groups of cases with individual law firms after losing several bellwether trials. In the first trial in 2013, a New Jersey jury returned an $11 million verdict against Ethicon for injuries caused by its Gynecare Prolift.
In February 2023, Ethicon paid nearly $10 million to settle the state of Kentucky’s claims that the company “violated the Kentucky Consumer Protection Act by misrepresenting or failing to adequately disclose serious and life-altering risks of surgical mesh devices when marketing the product to doctors, as required by the U.S. Food and Drug Administration.”
Ethicon challenged a $302 million judgment from a lawsuit brought by the state of California over the company’s pelvic mesh devices. In 2023, the U.S. Supreme Court upheld the verdict.
As of September 2024, there were 27 Ethicon cases open or pending in a federal MDL.
C.R. Bard settled or otherwise resolved most of its federal transvaginal mesh MDL cases, but as of September 2024 , a group of federal cases still exists in New Jersey multicounty litigation. According to court documents, the court officially transferred these cases from Judge Brian R. Martinotti to Superior Court Judge Rachelle L. Harz in June 2023. Seven of these cases have been stayed through March 2024 as they continue to progress through the settlement process.
After losing a state lawsuit for $3.6 million in 2012 and a federal lawsuit for $2 million in 2013, Bard settled a pair of cases for undisclosed amounts. In October 2014, Bard settled more than 500 lawsuits for $21 million, but the judge presiding over the MDL was disturbed by Bard’s slow pace.
In December 2014, Judge Joseph Goodwin told Bard to settle additional cases or face billions of dollars in jury verdicts. In August 2015, Bard settled another 3,000 cases for $200 million and a number of others for confidential amounts. In 2020, the company agreed to pay $60 million to settle vaginal mesh claims with 48 states.
American Medical Systems was the first company to offer a substantial transvaginal mesh settlement when it agreed to pay up to $830 million to settle 20,000 claims in 2014. Before this settlement, the company offered to pay $54.5 million to settle an undisclosed group of cases.
According to Bloomberg, American Medical Systems’ parent company, Endo International, set aside $775 million to settle 22,000 claims in August 2017. In total, the company has spent about $2.6 billion to settle its mesh cases.
As of September 2024 , the company hasn’t announced any additional transvaginal mesh settlements. Per its most recent annual report, Endo International had liabilities of around $50.7 million held in Qualified Settlement Funds (QSFs) for pelvic mesh cases in the USA.
In March 2023, an Australian federal court approved Boston Scientific’s $105 million offer to settle a class-action lawsuit. In 2021, the company entered into a $189 million settlement agreement with 47 states over its vaginal mesh devices.
Boston Scientific lost multiple jury verdicts before settling3,000 mesh lawsuits for $119 millionin April 2015. In December 2017, the company settled an additional 350 lawsuits for an undisclosed amount.
According to the company’s 2018 annual report, Boston Scientific “entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs’ counsel to resolve an aggregate of approximately 50,000 cases and claims.”
Coloplast faced the second-fewest lawsuits in the West Virginia MDL. The company announced it would settle about 400 mesh lawsuits for $16 million in January 2014. The claimants reportedly received about $40,000.
The company hasn’t reported any more settlements or jury verdicts as of September 2024 . According to its 2022/2023 annual report, Coloplast now considers its MDL cases closed.
See if You Qualify for a Lawsuit Our PartnersDrugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.
Did you experience organ perforation, bleeding or other serious injuries from your transvaginal mesh implant?
As of September 2024 , average vaginal mesh settlement amounts have ranged from $40,000 to $450,000. Plaintiffs who have taken their cases to trial have received millions in jury verdicts, but some of these verdicts have been overturned or reduced after appeal.
How much each plaintiff could receive in a transvaginal mesh settlement depends on several factors, including the severity of physical injuries, the age of the plaintiff and the extensiveness of treatment. Experienced transvaginal mesh lawyers can help clients maximize their settlement amounts.
Transvaginal mesh settlements could take anywhere from six months to several years. At one time, more than 100,000 transvaginal mesh lawsuits were pending in federal multidistrict litigation, so settlements took longer.
Because the bulk of these cases have been resolved, future transvaginal mesh settlements could happen more quickly. Sometimes, companies may offer to settle a case right before it heads to trial.
Anyone who has endured injuries from a transvaginal mesh implant and received treatment could potentially qualify for a transvaginal mesh settlement. Most attorneys still taking cases are restricting them to clients who have recently had the mesh removed or who required revision surgeries. Only a transvaginal mesh lawyer can tell you if you qualify.
Lawyers will see if you qualify by asking you several questions about your transvaginal mesh experience. These include when you received your implant, when you started experiencing problems and what kind of treatments you received for complications.
There are time limits to filing a lawsuit for a potential transvaginal mesh settlement, so it’s important to seek help from a lawyer right away. If the statute of limitations has passed on your case, you will not be able to file a claim. Even if you think the time limit has passed, talk to a lawyer about your legal options.
Please seek the advice of a medical professional before making health care decisions.We appreciate your feedback. One of our content team members will be in touch with you soon.
We appreciate your feedback. One of our content team members will be in touch with you soon.
Written By Last Modified: June 6, 2024 Fact-CheckedEditors carefully fact-check all Drugwatch.com content for accuracy and quality.
Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.
We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:
Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.
View SourcesCalling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
Subscribe to Our NewsletterJoin our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more.
NavigateKeep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.
Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801
The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.
Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.
© 2024 Drugwatch.com Privacy Policy / Advertising Disclosure / Do Not Sell My Info
California Consumer Privacy Act (CCPA) InquiriesDrugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you would like to speak with a Drugwatch representative, please call 888-645-1617
